Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control-Reference-Cited by-同舟云学术

Using treatment interruptions to palliate the toxicity from concurrent chemoradiation for limited small cell lung cancer decreases survival and disease control

Published:2001-08 Issue:2-3 Volume:33 Page:249-258
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Videtic Gregory M.M,Fung Karen,Tomiak Anna T,Stitt Larry W,Dar A.Rashid,Truong Pauline T,Yu Edward W,Vincent Mark D,Kocha Walter I

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference23 articles.

1. Experimental chemotherapy;Tannock,1992

2. Radiotherapy in limited small cell lung cancer: fractionation and timing of modalities;Turrisi;Semin. Radiat. Oncol.,1995

3. Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer;Murray;J. Clin. Oncol.,1993

4. Randomized study of initial versus late chest irradiation combined with chemotherapy in limited-stage small-cell lung cancer;Work;J. Clin. Oncol.,1997

5. Chemotherapy with or without radiation therapy in limited small-cell carcinoma of the lung;Perry;New Engl. J. Med.,1987

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chinese expert consensus on the application of pegylated recombinant human granulocyte colony‐stimulating factor during concurrent chemoradiotherapy (2023 edition);Precision Radiation Oncology;2023-09

2. Web-Based Symptom Monitoring With Patient-Reported Outcomes During Definitive Radiation Therapy With Chemotherapy (SYMPATHY): A Prospective Single-Center Phase 1 Study;Advances in Radiation Oncology;2022-10

3. A retrospective study of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in preventing neutropenia during definitive concurrent chemoradiotherapy in patients with esophageal squamous carcinoma;Radiation Medicine and Protection;2022-06

4. GOECP/SEOR radiotherapy guidelines for small-cell lung cancer;World Journal of Clinical Oncology;2021-03-24

5. Chinese expert consensus on the application of pegylated recombinant human granulocyte colony‐stimulating factor during concurrent chemoradiotherapy (2020 edition);Precision Radiation Oncology;2021-03